Project Grant R01EY037077

Award Date 5/1/25
Completion Date 4/30/30
Dollars Obligated $477K
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
The National Eye Institute (NEI) awarded Duke University a $201,250 Project Grant under the NIH Vision Research program (CFDA 93.867) to characterize the unique proteome of the photoreceptor outer-inner segment junction in the retina. The goal is to reduce the knowledge gap regarding the protein composition and molecular mechanisms of this critical cellular region, which plays a key role in photoreceptor function and is implicated in various retinal degenerative diseases. The project will employ...
The National Eye Institute (NEI) awarded a $388,750 Project Grant (CFDA 93.867 Vision Research) to The Washington University to investigate the role of histone variant H3.3 in retinal cell fate specification and differentiation. The five-year project, running from August 1, 2024 to July 31, 2029, aims to characterize the retinal phenotype after depleting H3.3 and define its function in retinal epigenetic remodeling and homeostasis. By advancing the understanding of H3.3's role in the retina, the...
The National Eye Institute (NEI) awarded a $1,490,141 Project Grant under the Vision Research program (CFDA 93.867) to the Regents of the University of Michigan to investigate photoreceptor nuclear migration defects caused by loss of the retinitis pigmentosa 2 (RP2) gene. The project aims to determine how this developmental phenotype affects photoreceptor function and health, explore methods to restore normal photoreceptor nuclear localization, and identify the ciliary signaling mechanism...
This is a Project Grant award from the National Eye Institute (NEI), part of the National Institutes of Health (NIH), under the Vision Research program (CFDA 93.867). The $451,000 award supports research by the University of Texas Southwestern Medical Center to investigate the role of the FIC enzyme in regulating the unfolded protein response (UPR) in the mammalian retina. Specifically, the project aims to determine if FIC-mediated modification of the BIP protein can modulate UPR activation,...
The National Eye Institute (NEI) awarded a $624,230 Project Grant (CFDA 93.867 Vision Research) to the University of California, Los Angeles (UCLA) to conduct research on the physiology of retinal degeneration. The key objectives of the 4-year project are to: 1) Document changes in rod photoreceptor function and connectivity to rod bipolar cells as retinal degeneration progresses in mouse models, and 2) Investigate how the retina adapts to photoreceptor loss through synaptic remodeling and...
The National Eye Institute (NEI) awarded a $595,302 Project Grant (CFDA 93.867 Vision Research) to Thomas Jefferson University, doing business as Sidney Kimmel Medical College, to conduct research on how glucose transport and metabolism support the health and function of the retina and photoreceptors. The 5-year project, running from April 1, 2025 to March 31, 2030, will investigate the roles of the retinal pigment epithelium (RPE) and rod photoreceptors in utilizing glucose, as well as how...
The National Eye Institute (NEI) awarded a $480,376 Project Grant (CFDA 93.867 - Vision Research) to The Washington University in St. Louis to investigate the regulation of retinal development by RNA molecules. The project aims to examine the role of long non-coding RNAs (lncRNAs) in controlling retinal gene regulatory networks, including through interactions with key transcription factors. The research will utilize both gain-of-function and loss-of-function models to study the effects of the...
The National Eye Institute (NEI) awarded a $436,544 Project Grant (CFDA 93.867 Vision Research) to the University of Oklahoma Health Sciences Center to investigate the transfer of extracellular microRNAs (miRNAs) between retinal pigment epithelium (RPE) and microglia as a means of intercellular communication, and to evaluate the use of engineered RPE-derived extracellular vesicles (EVs) as an interventional strategy to mitigate retinal inflammation and injury. The project aims to provide...
This Project Grant award of $413,741 from the National Eye Institute (NEI) Vision Research federal grant program (CFDA 93.867) supports research at the University of Pittsburgh to investigate the chromatin-based regulatory mechanisms underlying retinal development and the genetic and epigenetic circuits that drive retinal transcription programs. The research aims to provide a deep understanding of how the wiring and rewiring of the chromatin landscape enables the precise spatial and temporal...
This $1,789,542 federal Project Grant award from the National Eye Institute (NEI), under the CFDA 93.867 Vision Research program, supports a research project to study the role of modular super-enhancers in regulating gene expression during retinal development in mice and humans. The award aims to identify developmental stage- and cell type-specific promoter-super-enhancer interactions for key retinal transcription factor genes, which is critical for understanding the non-coding genome's...

The National Eye Institute (NEI) awarded a $477,109 Project Grant (CFDA 93.867 - Vision Research) to the University of Texas Southwestern Medical Center to investigate how the PRDM13 transcriptional regulator influences retinal development and photoreceptor cell fate. The research aims to further the understanding of mammalian retinal development and mechanisms underlying healthy retinogenesis. The project period runs from May 1, 2025 to April 30, 2030. The research will explore how disruptions in PRDM13 activity contribute to retinal abnormalities, such as those seen in North Carolina Macular Dystrophy, with implications for future cellular therapies and treatments to preserve vision.

Generated 5/13/25, 3:36 AM